Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer

Patients with cancer and diabetes face unique challenges. Limited data are available on diabetes management in patients undergoing concurrent chemoradiotherapy (CCRT), a curative intent anticancer therapy commonly associated with glucocorticoid administration, weight fluctuations and enteral feeds....

Full description

Bibliographic Details
Main Authors: Rhiannon Mellor, Christian M. Girgis, Anthony Rodrigues, Charley Chen, Sonia Cuan, Parvind Gambhir, Lakmalie Perera, Michael Veness, Purnima Sundaresan, Bo Gao
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/31/2/61
_version_ 1797298512526835712
author Rhiannon Mellor
Christian M. Girgis
Anthony Rodrigues
Charley Chen
Sonia Cuan
Parvind Gambhir
Lakmalie Perera
Michael Veness
Purnima Sundaresan
Bo Gao
author_facet Rhiannon Mellor
Christian M. Girgis
Anthony Rodrigues
Charley Chen
Sonia Cuan
Parvind Gambhir
Lakmalie Perera
Michael Veness
Purnima Sundaresan
Bo Gao
author_sort Rhiannon Mellor
collection DOAJ
description Patients with cancer and diabetes face unique challenges. Limited data are available on diabetes management in patients undergoing concurrent chemoradiotherapy (CCRT), a curative intent anticancer therapy commonly associated with glucocorticoid administration, weight fluctuations and enteral feeds. This retrospective case–control study examined the real-world incidence of acute diabetes-related complications in patients with head and neck cancer receiving CCRT, along with the impact of diabetes on CCRT tolerance and outcomes. Methods: Consecutive patients with head and neck squamous cell or nasopharyngeal cancer who underwent definitive or adjuvant CCRT between 2010 and 2019 at two large cancer centers in Australia were included. Clinicopathological characteristics, treatment complications and outcomes were collected from medical records. Results: Of 282 patients who received CCRT, 29 (10.3%) had pre-existing type 2 diabetes. None had type 1 diabetes. The majority (74.5%) required enteral feeding. A higher proportion of patients with diabetes required admission to a high-dependency or intensive care unit (17.2 versus 4.0%, <i>p</i> = 0.003). This difference was driven by the group who required insulin at baseline (<i>n</i> = 5), of which four (80.0%) were admitted to a high-dependency unit with diabetes-related complications, and three (60.0%) required omission of at least one cycle of chemotherapy. Conclusions: Patients with diabetes requiring insulin have a high risk of acute life-threatening diabetes-related complications while receiving CCRT. We recommend multidisciplinary management involving a diabetes specialist, educator, dietitian, and pharmacist, in collaboration with the cancer care team, to better avoid these complications.
first_indexed 2024-03-07T22:36:54Z
format Article
id doaj.art-c9bd0a0ec68544358253f0c0856925f5
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-07T22:36:54Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-c9bd0a0ec68544358253f0c0856925f52024-02-23T15:13:24ZengMDPI AGCurrent Oncology1198-00521718-77292024-02-0131282883810.3390/curroncol31020061Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck CancerRhiannon Mellor0Christian M. Girgis1Anthony Rodrigues2Charley Chen3Sonia Cuan4Parvind Gambhir5Lakmalie Perera6Michael Veness7Purnima Sundaresan8Bo Gao9Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, AustraliaDepartment of Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW 2145, AustraliaThe Kinghorn Cancer Centre, St Vincent’s Hospital, Darlinghurst, NSW 2010, AustraliaBlacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, AustraliaCrown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, AustraliaBlacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, AustraliaNepean Cancer Care Centre, Nepean Hospital, Kingswood, NSW 2747, AustraliaCrown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, AustraliaCrown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, AustraliaCrown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, AustraliaPatients with cancer and diabetes face unique challenges. Limited data are available on diabetes management in patients undergoing concurrent chemoradiotherapy (CCRT), a curative intent anticancer therapy commonly associated with glucocorticoid administration, weight fluctuations and enteral feeds. This retrospective case–control study examined the real-world incidence of acute diabetes-related complications in patients with head and neck cancer receiving CCRT, along with the impact of diabetes on CCRT tolerance and outcomes. Methods: Consecutive patients with head and neck squamous cell or nasopharyngeal cancer who underwent definitive or adjuvant CCRT between 2010 and 2019 at two large cancer centers in Australia were included. Clinicopathological characteristics, treatment complications and outcomes were collected from medical records. Results: Of 282 patients who received CCRT, 29 (10.3%) had pre-existing type 2 diabetes. None had type 1 diabetes. The majority (74.5%) required enteral feeding. A higher proportion of patients with diabetes required admission to a high-dependency or intensive care unit (17.2 versus 4.0%, <i>p</i> = 0.003). This difference was driven by the group who required insulin at baseline (<i>n</i> = 5), of which four (80.0%) were admitted to a high-dependency unit with diabetes-related complications, and three (60.0%) required omission of at least one cycle of chemotherapy. Conclusions: Patients with diabetes requiring insulin have a high risk of acute life-threatening diabetes-related complications while receiving CCRT. We recommend multidisciplinary management involving a diabetes specialist, educator, dietitian, and pharmacist, in collaboration with the cancer care team, to better avoid these complications.https://www.mdpi.com/1718-7729/31/2/61head and neck cancerchemoradiotherapymanagementdiabetesdiabetes complications
spellingShingle Rhiannon Mellor
Christian M. Girgis
Anthony Rodrigues
Charley Chen
Sonia Cuan
Parvind Gambhir
Lakmalie Perera
Michael Veness
Purnima Sundaresan
Bo Gao
Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
Current Oncology
head and neck cancer
chemoradiotherapy
management
diabetes
diabetes complications
title Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
title_full Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
title_fullStr Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
title_full_unstemmed Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
title_short Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
title_sort acute diabetes related complications in patients receiving chemoradiotherapy for head and neck cancer
topic head and neck cancer
chemoradiotherapy
management
diabetes
diabetes complications
url https://www.mdpi.com/1718-7729/31/2/61
work_keys_str_mv AT rhiannonmellor acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT christianmgirgis acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT anthonyrodrigues acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT charleychen acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT soniacuan acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT parvindgambhir acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT lakmalieperera acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT michaelveness acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT purnimasundaresan acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer
AT bogao acutediabetesrelatedcomplicationsinpatientsreceivingchemoradiotherapyforheadandneckcancer